Comparative Performance of Three Metabolic Syndrome Definitions in the Prediction of Acute Coronary Syndrome

Abstract

Objective The value of the recently introduced definitions of metabolic syndrome (MetS)

Circunferência abdominal como preditor de evolução em 30 dias na síndrome coronariana aguda

“…Regarding the type of ACS, 38.8% (19) of male patients and 44.9% (22) of females with increased AC were hospitalized for AMI with no ST-segment elevation or UA and 61.2% (30) of men and 55.1% (27) of women for AMI with ST-segment elevation (p = 0.45; p = 0.68, respectively).…”

“…Bonarjee et al 29 evaluating short and long term survival of patients with AMI, found that women have a higher risk of death from any cause and from cardiovascular disease, re-AMI and rehospitalization for coronary artery bypass grafting (p < 0.00). However, Tarastchuk et al 30 found an association between increased AC (male 90 cm and female 80 cm) and cardiac outcomes after percutaneous coronary intervention, only in males.…”

“…In this case, the only significant anthropometric measure was WHR. Tarastchuk et al 30 found that 43.8% of patients WHO had outcomes after percutaneous coronary intervention had a family history of ischemic heart disease.…”

Is there any difference in severe erectile dysfunction detection when different diagnostic metabolic syndrome criteria are used?

“…However, some researchers have an opposite opinion. [22,23] In our study, MS was identified in approximately half of the patients with ED. The risk for ED was higher in patients with MS.…”

Arterial stiffness predicts risk for long-term recurrence in patients with type 2 diabetes admitted for acute coronary event

“…End-points were: death due to CVD, recurrent acute coronary syndrome (ACS), nonelective coronary artery revascularization, and hospitalization for acute heart failure. Death due to CVD was defined as (1) sudden, unexplained death (2) fatal myocardial infarction (3) death from acute heart failure or myocardial ischemia and (4) death from stroke or peripheral artery disease [15]. Patients reaching their first primary end-point were excluded from further follow-up.…”